Supporters of ovarian cancer patient decry BioMarin CEO's apparent email goof
September 18, 2013 at 16:52 PM EDT
An apparent slip-up in sending an email — hitting "reply all," instead of "forward" — has landed BioMarin Pharmaceutical Inc...